Chicken adverse-event record

Chicken Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 662 adverse event reports for Chicken, distributed across 4 distinct breeds currently tracked in the system. Of those reports, 412 involved a death outcome, producing a 62.2% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Chicken are Death (268 reports), Lack of efficacy (protozoa) - Coccidia (142 reports), Lack of efficacy - NOS (102 reports), Increased mortality rate (94 reports), with Death leading the reaction traffic at 268 submissions. On the product side, Narasin + Nicarbazin is the single most-referenced drug with 163 reports, followed by Narasin (121), Monensin Sodium (94), Tylosin (34). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species, a useful starting point when comparing Chicken reporting patterns against other companion animals in the dataset.

Of the 761 Chicken reports with a coded outcome, Died accounts for the largest share at 51.4%. Annual submission volume spans 8 to 60 reports across the 17 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 4 tracked chicken breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling, causation requires clinical investigation beyond what these aggregates can provide.